Peter Airel, MD
Gastroenterology · Las Vegas, NVNPI 1538222047
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 33.4% of the total. Reporting peaked in 2022 at $217 and has fallen 91.0% since, to $19 in 2025. That places this record below the midpoint for gastroenterology clinicians in NV, where the typical reported total is $3,212.
Across 17 payments — averaging $23.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$134
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$85
- Johnson & Johnson$48
- Amgen$31
- Intercept Pharmaceuticals, Inc.$20
- Ardelyx, Inc.$19
- plus $63 from 4 others
What the payments were for
- Food & beverage$400100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 2 | $134 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $85 |
| Johnson & Johnson | 2 | $48 |
| Amgen | 2 | $31 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
| Ardelyx, Inc. | 1 | $19 |
| Sanofi | 1 | $18 |
| Boston Scientific | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Capsovision, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$117
How this compares
$400 in reported general payments places this provider in the 15th percentile of 103 gastroenterology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 14 | $2,427 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 100 | $1,564 |
| Dexlansoprazole DrDexlansoprazole | 12 | $1,191 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 11 | $693 |
| Omeprazole | 24 | $469 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Las Vegas
- Christian StoneLas Vegas$1.1M
- James HanLas Vegas$47K
- Filippo CremoniniLas Vegas$36K
- Vijay JayaramanLas Vegas$28K
- Gary ChenLas Vegas$27K
- David ShihLas Vegas$26K
- Noel FajardoLas Vegas$22K
- Frank FarisLas Vegas$14K
- Tarek AmmarLas Vegas$14K
- Eladio CarreraLas Vegas$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.